NCT07698405

Brief Summary

This study aims to evaluate the effect of a personalized technology-based rehabilitative intervention on Upper Limb (UL) motor function and capacity recovery in People with Stroke (PwS). The study is single-cohort study in which eligible participants will undergo baseline and follow-up clinical and instrumental assessments over a 4-5 week period. The intervention consists of a personalized and specific upper limb technology-based rehabilitation programme delivered three times per week for a total of 12-15 sessions. Each session lasts approximately one hour and is integrated with conventional rehabilitation treatments. Primary outcomes include Fugl-Meyer Assessment for Upper Extremity (FMA-UE) and Action Research Arm Test (ARAT). Secondary outcomes include instrumental assessment of active range of motion and grip strength.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
10mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress27%
Jun 2026Aug 2027

Study Start

First participant enrolled

June 15, 2026

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

July 7, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

September 22, 2026

Status Verified

July 1, 2026

Enrollment Period

1.1 years

First QC Date

July 7, 2026

Last Update Submit

September 17, 2026

Conditions

Keywords

StrokeTechnology-Assisted RehabilitationRoboticsVirtual RealityMotor Recovery

Outcome Measures

Primary Outcomes (2)

  • Fugl-Meyer Assessment for Upper Extremity (FMA-UE)

    Fugl-Meyer Assessment for Upper Extremity (FMA-UE) is an ordinal scale used to assess sensorimotor function following stroke. The upper extremity motor function section includes four subscales assessing synergistic and non-synergistic movements of shoulder, elbow, wrist and hand, as well as coordination/speed. The maximum score is 66 points, indicating normal upper limb motor function. In addition to motor function, the FMA-UE assesses Non-motor domains (i.e., sensation, passive joint movement and pain), with a maximum total score of 60 points.

    Baseline (T0) at enrollment, and after 4-5 weeks of observation (T1)

  • Action Research Arm Test (ARAT)

    Action Research Arm Test (ARAT) consists of 19 items grouped in subtests (i.e., grasp, grip, pinch, and gross arm movement) and performance of each item rated on a 4 points scale (from 0 - no movement possible, to 3 - movement performed normally.

    Baseline (T0) at enrollment, and after 4-5 weeks of observation (T1)

Secondary Outcomes (2)

  • Instrumented Active Range of Motion (AROM) of affected Upper Limb

    Baseline (T0) at enrollment, and after 4-5 weeks of observation (T1)

  • Instrumental gross and fine motor grip strength of hand affected

    Baseline (T0) at enrollment, and after 4-5 weeks of observation (T1)

Other Outcomes (8)

  • National Institute of Health Stroke Scale Italian version (NIHSS-IT)

    Baseline (T0) at enrollment

  • Oxford Community Stroke Project (OCSP)

    Baseline (T0) at enrollment

  • Modified Ashworth Scale (MAS)

    Baseline (T0) at enrollment

  • +5 more other outcomes

Study Arms (1)

PwS

Adult People with Stroke (PwS) with Upper Limb (UL) motor function impairment

Device: Technology-based UL rehabilitation

Interventions

Participants will receive conventional treatments, including neuromotor, occupational therapy, speech therapy and/or neuropsychology treatments, as clinically indicated. In addition, they will undergo a personalized and specific UL technology-based rehabilitation programme, delivered 3 times per week, for a total of 12 - 15 sessions. Each session will last 1 hour and will be conducted in a 1:1 format (physiotherapist : participant). Data on rehabilitation dosage will be collected, including the total number of hours of rehabilitation received. Physiotherapists who will have in charge participant, will compiled a treatment diary for each technology session in which they will record: number of session, total hour of technology-based treatments, type of device used and any adverse events.

PwS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult PwS admitted to the Intensive Rehabilitation Unit at Fiorenzuola d'Arda hospital. Sampling will be consecutive and carried out on the basis of feasibility and the flow of admissions to the Clinical Unit, amounting to approximately 3-5 individuals per month. The study will include PwS who meet eligibility criteria at the time of recruitment and who are able to understand and provide informed consent to participate.

You may qualify if:

  • Age ≥ 18 years;
  • First-ever unilateral ischemic or hemorrhagic stroke;
  • Presence of upper limb motor impairment;
  • Modified Ashworth Scale (MAS) \< 3;
  • Montreal Cognitive Assessment (MoCA) \> 24;
  • Medically stable and able to participate in an intensive rehabilitation programme;
  • Ability to understand and follow study procedures;
  • Written informed consent.

You may not qualify if:

  • Diagnosis of severe aphasia, based on medical records, preventing participation;
  • Bilateral hemisphere lesions;
  • Severe and unstable medical conditions (e.g. untreated seizure, heart failure) that preclude participation in rehabilitation;
  • Other neurological and/or psychiatric diseases;
  • Recent and unstabilized upper limb fracture.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fiorenzuola d'Arda Hospital - AUSL Piacenza

Fiorenzuola d'Arda, Piacenza, 29017, Italy

RECRUITING

Related Publications (17)

  • Saposnik G, Levin M; Outcome Research Canada (SORCan) Working Group. Virtual reality in stroke rehabilitation: a meta-analysis and implications for clinicians. Stroke. 2011 May;42(5):1380-6. doi: 10.1161/STROKEAHA.110.605451. Epub 2011 Apr 7.

    PMID: 21474804BACKGROUND
  • Yoo SD, Lee HH. The Effect of Robot-Assisted Training on Arm Function, Walking, Balance, and Activities of Daily Living After Stroke: A Systematic Review and Meta-Analysis. Brain Neurorehabil. 2023 Sep 20;16(3):e24. doi: 10.12786/bn.2023.16.e24. eCollection 2023 Nov.

    PMID: 38047093BACKGROUND
  • O'Flaherty D, Ali K. Recommendations for Upper Limb Motor Recovery: An Overview of the UK and European Rehabilitation after Stroke Guidelines (2023). Healthcare (Basel). 2024 Jul 18;12(14):1433. doi: 10.3390/healthcare12141433.

    PMID: 39057576BACKGROUND
  • Collin C, Wade D. Assessing motor impairment after stroke: a pilot reliability study. J Neurol Neurosurg Psychiatry. 1990 Jul;53(7):576-9. doi: 10.1136/jnnp.53.7.576.

    PMID: 2391521BACKGROUND
  • Kwakkel G, Kollen BJ, Krebs HI. Effects of robot-assisted therapy on upper limb recovery after stroke: a systematic review. Neurorehabil Neural Repair. 2008 Mar-Apr;22(2):111-21. doi: 10.1177/1545968307305457. Epub 2007 Sep 17.

    PMID: 17876068BACKGROUND
  • Veerbeek JM, van Wegen E, van Peppen R, van der Wees PJ, Hendriks E, Rietberg M, Kwakkel G. What is the evidence for physical therapy poststroke? A systematic review and meta-analysis. PLoS One. 2014 Feb 4;9(2):e87987. doi: 10.1371/journal.pone.0087987. eCollection 2014.

    PMID: 24505342BACKGROUND
  • Mehrholz J, Pollock A, Pohl M, Kugler J, Elsner B. Systematic review with network meta-analysis of randomized controlled trials of robotic-assisted arm training for improving activities of daily living and upper limb function after stroke. J Neuroeng Rehabil. 2020 Jun 30;17(1):83. doi: 10.1186/s12984-020-00715-0.

    PMID: 32605587BACKGROUND
  • MAHONEY FI, BARTHEL DW. FUNCTIONAL EVALUATION: THE BARTHEL INDEX. Md State Med J. 1965 Feb;14:61-5. No abstract available.

    PMID: 14258950BACKGROUND
  • Mathiowetz V, Volland G, Kashman N, Weber K. Adult norms for the Box and Block Test of manual dexterity. Am J Occup Ther. 1985 Jun;39(6):386-91. doi: 10.5014/ajot.39.6.386.

    PMID: 3160243BACKGROUND
  • McDonnell M. Action research arm test. Aust J Physiother. 2008;54(3):220. doi: 10.1016/s0004-9514(08)70034-5. No abstract available.

    PMID: 18833688BACKGROUND
  • Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S. The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975;7(1):13-31.

    PMID: 1135616BACKGROUND
  • Lang CE, Edwards DF, Birkenmeier RL, Dromerick AW. Estimating minimal clinically important differences of upper-extremity measures early after stroke. Arch Phys Med Rehabil. 2008 Sep;89(9):1693-700. doi: 10.1016/j.apmr.2008.02.022.

    PMID: 18760153BACKGROUND
  • Arya KN, Verma R, Garg RK. Estimating the minimal clinically important difference of an upper extremity recovery measure in subacute stroke patients. Top Stroke Rehabil. 2011 Oct;18 Suppl 1:599-610. doi: 10.1310/tsr18s01-599.

    PMID: 22120029BACKGROUND
  • Cicerone Consensus Conference. Linee di indirizzo per l'utilizzo delle tecnologie riabilitative. Consensus Conference CICERONE 2022

    BACKGROUND
  • Loureiro RC, Harwin WS, Nagai K, Johnson M. Advances in upper limb stroke rehabilitation: a technology push. Med Biol Eng Comput. 2011 Oct;49(10):1103-18. doi: 10.1007/s11517-011-0797-0. Epub 2011 Jul 20.

    PMID: 21773806BACKGROUND
  • Veerbeek JM, Langbroek-Amersfoort AC, van Wegen EE, Meskers CG, Kwakkel G. Effects of Robot-Assisted Therapy for the Upper Limb After Stroke. Neurorehabil Neural Repair. 2017 Feb;31(2):107-121. doi: 10.1177/1545968316666957. Epub 2016 Sep 24.

    PMID: 27597165BACKGROUND
  • GBD 2021 Stroke Risk Factor Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol. 2024 Oct;23(10):973-1003. doi: 10.1016/S1474-4422(24)00369-7.

    PMID: 39304265BACKGROUND

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Gianfranco Lamberti, MD

    Azienda Unita Sanitaria Locale di Piacenza

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gianfranco Lamberti, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 13, 2026

Study Start

June 15, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

September 22, 2026

Record last verified: 2026-07

Locations